News|Articles|November 16, 2026

Weekly review: Testosterone’s history, Peri-SS symptom scale, and more

Fact checked by: Ben Saylor

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, November 9, to Friday, November 13, 2026) and click on each link to read and watch anything you may have missed.

Testosterone in women: Early history of androgen therapy

In the first episode of a Special Report series, moderator Bruce Dorr, MD, FACOG, URPS, IFMCP, and Sharon J. Parish, MD, IF, NCMP, trace the history of androgen therapy in women, including 1970s and 1980s research by Helen Singer Kaplan on small-dose testosterone implants for sexual desire, with Parish noting that the barrier to therapy has been the lack of long-term safety data rather than efficacy.

Click here to watch the first episode in the series.

Liudmila Zhaunova talks global Flo app data on perimenopause and activity

Perimenopausal women who are more physically active report a lower symptom burden, according to a global cross-sectional study of 1808 Flo app users across 87 countries presented at The Menopause Society 2026 Annual Meeting, with coauthor Liudmila Zhaunova of Flo Health in London noting that the largest difference appeared between no activity and even a few sessions a month.

Click here to watch the full discussion with Liudmila Zhaunova.

Peri-SS shows reliability for tracking perimenopause symptoms

The 16-item Perimenopause Symptom Scale (Peri-SS) showed strong reliability and validity among 1255 women aged 35 to 59 years in the United States, with excellent internal consistency and high test-retest reliability, according to a validation study published in Menopause.

Click here for full study details.

Adverse pregnancy outcomes tied to postpartum contraceptive choices

Patients who experienced 3 or more adverse pregnancy outcomes were less likely to use contraception after delivery, and those with at least 1 adverse outcome who did use contraception were more likely to choose a permanent method, according to a Pregnancy Risk Assessment Monitoring System analysis of 222,412 individuals published in Obstetrics & Gynecology.

View the details here.

Risa Kagan, MD, on bone health across a woman's lifetime

The menopause transition is a critical window when bone loss accelerates, with women losing 10% to 12% of bone mass, and preserving it takes strength training, fall prevention, and adequate calcium and vitamin D, according to Risa Kagan, MD, FACOG, CCD, MSCP, clinical professor in the department of obstetrics, gynecology, and reproductive sciences at the University of California, San Francisco.

Click here to watch the full discussion with Risa Kagan, MD, FACOG, CCD, MSCP.


Related to this article